John Stanford
speaker
1,479 appearances
11 recordings
1 series
first heard May 2026
last heard 13 Aug
John Stanford’s voice in public audio — every appearance, attributed to the second.
Trend
recordings per month · last 12 monthsRecordings per month over the last 12 months — 11 in all, peaking in Jul 2026 with 4.
Appearances
Pharmacists began producing medicines in consistent quantities, and new manufacturing methods allowed treatments to travel farther and reach more people.
The medicine was no longer simply whatever happened to be mixed in the back of a local shop.
It could be formulated, tested, packaged, and reproduced.
That shift from remedy to reproducible product was fundamental.
It was also, in a sense, anticipated by the founders themselves.
Just 11 years after the Declaration of Independence, the framers wrote a specific incentive for invention directly into the Constitution.
Article 1, Section 8 gives Congress the power to promote the progress of science and useful arts by securing inventors.
The exclusive rights to their discoveries for a limited time.
That single clause, the constitutional basis for the American patent system, created the economic logic that would eventually make modern drug development possible.
But let's not get ahead of ourselves.
These new inventions and the new ability for doctors to propose new solutions also created a new problem.
How could the public, as it got to know more about medicine, actually trust what was inside the bottle?
the answer became another important part of the American pharmaceutical innovation model.
Scientific progress in the field would be paired with standards, oversight, and evidence so that Americans could trust the drugs they were getting.
Fortunately, at the turn of the 20th century, Congress got involved.
The 1906 Pure Food and Drugs Act prohibited certain forms of misbranding and adulteration.
A few decades later, the 1938 Federal Food, Drug, and Cosmetic Act required
Manufacturers to demonstrate that new drugs were safe before marketing them.
It was these pieces of legislation and their implementation that began to put in the minds of Americans that we can trust the medicines coming from the next generation of manufacturers.
But it would be a few decades later, in the early 1960s, when one FDA reviewer became a symbol of why that rigorous scrutiny would matter.
Showing 481–500 of 1,479 · page 25 of 74
← Previous
Next →